Search results

Skip to results

Area of interest

Area of interest

Type

Type

Last updated

Last updated

Advice programme

Showing 1 result for oritavancin

  1. Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections (ES39)

    Summary of the evidence on oritavancin for acute bacterial skin and skin structure infections (ABSSSI) in adults

    Evidence summary
    Published
    11 May 2022